Mark Matulenko

Q: What is Mark Matulenko email address?

Email Mark Matulenko at matulenko@comcast.net and mark.matulenko@abbvie.co.jp. This email is the most updated Mark Matulenko's email found in 2026.

Q: How to contact Mark Matulenko?

To contact Mark Matulenko send an email to matulenko@comcast.net or mark.matulenko@abbvie.co.jp. (updated on September 01, 2024)

Principal Research Scientist I at AbbVie | Libertyville, Illinois, United States

About Mark Matulenko

Mark Matulenko is a seasoned Principal Research Scientist I at AbbVie, where he leverages his extensive expertise in medicinal chemistry to drive innovation in drug discovery. With a robust background in organic synthesis and a proven track record of identifying and optimizing lead candidates, Mark has played a pivotal role in advancing several therapeutic programs, particularly in urology, pain management, and hepatitis C virus (HCV) treatment. His collaborative efforts with diverse discovery teams, both within AbbVie and its predecessor, Abbott Laboratories, have culminated in the successful identification of six clinical candidates, underscoring his ability to navigate complex research landscapes.

Currently, Mark is focused on enhancing the capabilities of the Chemistry Technologies area within Global Pharmaceutical Research and Development (GPRD). His responsibilities primarily involve providing chemistry support through the Flexible Chemistry Group, where he is at the forefront of developing and implementing new synthetic methodologies. By utilizing cutting-edge techniques in parallel synthesis and purification, Mark aims to access more complex bioactive organic molecules, thereby improving the intellectual property (IP) positioning of potential drug candidates.

Mark's proficiency in analytical techniques such as LC-MS, NMR, and HPLC further complements his research endeavors, enabling him to purify and characterize compounds with precision. His commitment to lead change in pharmaceutical research is evident in his strategic approach to problem-solving and innovation, making him an invaluable asset to AbbVie’s mission of delivering transformative therapies to patients worldwide. Through his work, Mark continues to contribute to the advancement of the pharmaceutical industry, shaping the future of drug discovery with a focus on efficacy and safety.

Mark Matulenko Work